Literature DB >> 29523614

Selective internal radiation therapy (SIRT) with yttrium-90 microspheres for unresectable intrahepatic cholangiocarcinoma.

Vindya Abeysinghe1, Siva Sundararajan2, Luc Delriviere2, Jonathan Tibballs2.   

Abstract

Unresectableintrahepaticcholangiocarcinoma has a very poor prognosis despite various treatment options. The case presented describes the diagnostic challenges of a young pregnant woman with unresectable cholangiocarcinoma. The current treatment options for cholangiocarcinoma have limited evidence and high recurrence rate. Given the young age of this patient, selective internal radiotherapy was trialled with traditional chemotherapy with a clinically significant result. This case highlights the delays when diagnosing cholangiocarcinoma in younger patients and the possibility of selective internal radiation therapy in combination with chemotherapy as a potential first-line treatment for a complete response in unresectable disease. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  cancer intervention; hepatic cancer; malignant disease and immunosuppression

Mesh:

Substances:

Year:  2018        PMID: 29523614      PMCID: PMC5847944          DOI: 10.1136/bcr-2017-223539

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  18 in total

Review 1.  Intrahepatic cholestasis of pregnancy: molecular pathogenesis, diagnosis and management.

Authors:  F Lammert; H U Marschall; A Glantz; S Matern
Journal:  J Hepatol       Date:  2000-12       Impact factor: 25.083

Review 2.  Biliary tract cancers.

Authors:  P C de Groen; G J Gores; N F LaRusso; L L Gunderson; D M Nagorney
Journal:  N Engl J Med       Date:  1999-10-28       Impact factor: 91.245

3.  Y90-tagged microspheres in adjuvant tumor therapy.

Authors:  J W LAFAVE; I GROTENHUIS; Y S KIM; L D MACLEAN; J F PERRY
Journal:  Surgery       Date:  1963-06       Impact factor: 3.982

Review 4.  Intrahepatic cholangiocarcinoma.

Authors:  George A Poultsides; Andrew X Zhu; Michael A Choti; Timothy M Pawlik
Journal:  Surg Clin North Am       Date:  2010-08       Impact factor: 2.741

Review 5.  Physiologic skin changes in pregnancy.

Authors:  R C Wong; C N Ellis
Journal:  J Am Acad Dermatol       Date:  1984-06       Impact factor: 11.527

6.  Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer.

Authors:  Juan Valle; Harpreet Wasan; Daniel H Palmer; David Cunningham; Alan Anthoney; Anthony Maraveyas; Srinivasan Madhusudan; Tim Iveson; Sharon Hughes; Stephen P Pereira; Michael Roughton; John Bridgewater
Journal:  N Engl J Med       Date:  2010-04-08       Impact factor: 91.245

Review 7.  The epidemiology of cholangiocarcinoma.

Authors:  Yasser Shaib; Hashem B El-Serag
Journal:  Semin Liver Dis       Date:  2004-05       Impact factor: 6.115

8.  Intrahepatic cholangiocarcinoma masquerading as the HELLP syndrome (hemolysis, elevated liver enzymes, and low platelet count) in pregnancy: case report.

Authors:  K D Balderston; K Tewari; F Azizi; J K Yu
Journal:  Am J Obstet Gynecol       Date:  1998-09       Impact factor: 8.661

9.  Treatment of unresectable cholangiocarcinoma using yttrium-90 microspheres: results from a pilot study.

Authors:  Saad M Ibrahim; Mary F Mulcahy; Robert J Lewandowski; Kent T Sato; Robert K Ryu; Elizabeth J Masterson; Steven B Newman; Al Benson; Reed A Omary; Riad Salem
Journal:  Cancer       Date:  2008-10-15       Impact factor: 6.860

Review 10.  Treatment of unresectable intrahepatic cholangiocarcinoma with yttrium-90 radioembolization: a systematic review and pooled analysis.

Authors:  D P Al-Adra; R S Gill; S J Axford; X Shi; N Kneteman; S-S Liau
Journal:  Eur J Surg Oncol       Date:  2014-10-07       Impact factor: 4.424

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.